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Ammonia and cerebral water. Importance of structural analysis
of the brain in hepatic encephalopathy
To the Editor:
We read with interest the article by Mardini and colleagues [1],
who induced hyperammonaemia experimentally in patients with
cirrhosis. They show an increase in apparent diffusion coefﬁcient
(ADC) reported on diffusion tensor MR imaging (DTI) of the brain
and a decrease in frontal white matter (FWM) myo-inositol (mI)
demonstrated on concurrent 1H MR spectroscopy (MRS). These
imaging abnormalities were reported in the absence of a change
in cognitive status of the patients longitudinally across the study.
The authors conclude that this is further evidence of compen-
sated, low grade cerebral oedema in minimal hepatic encepha-
lopathy (MHE), but we would caution against this ﬁrm
conclusion in MHE patients, because the accumulated published
data are uncertain, owing to a lack of direct structural analysis
of brain volumes to date.
While measurement of ADC is a valid, but indirect method of
assessing shifts in brain water content in cellular compartments,
there is debate about the precise contribution to structural
changes and to the formation and nature of cerebral oedema
itself in MHE. Mardini and her group suggest that the low mI
detected on 1H MRS is proof of osmoregulatory compensation,
and that this supports the higher ADC measurements as repre-
senting a change in water movement and low grade (primarily
white matter) cerebral oedema. However, the authors do not
present direct structural data on gray or white matter volumes
to help support this conclusion in MHE patients.
Volumetric analysis of the brain has advanced mathematically
in recent years and small changes lower than 1% brain volume
change can be assessed by thorough MRI co-registration. We
have used co-registration techniques in patients with a previous
episode of overt hepatic encephalopathy and have demonstrated
changes in brain volume following a 4–6 week treatment with
lactulose [2], but with appropriate software, the technique is sen-
sitive enough to detect even very small brain volume changes
over short time frames of 2 h, such as in intense learning tasks
[3]. Voxel-based morphometry (VBM) allows sensitive detection
of regional brain volume changes, which would have supported
the MRS data on induced hyperammonaemia in Mardini’s elegant
study [4].
Given the lack of change in psychometric state in these
patients following the induced hyperammonaemia, it is question-
able as to whether the model used by Mardini’s team accurately
represented clinical decompensation in this instance. It could be
argued that hyperammonaemia alone is not sufﬁcient to cause
changes in cognitive state and that structural changes in addition
to changes in water compartmentalization are required. Volu-
metric analysis would have supported the main conclusions of
the paper. Since the acquisition parameters of the 3D 3T MRI data
used by Mardini and her co-workers still lend themselves to a
post hoc volumetric analysis, we believe that this would assist
hepatologists in their ongoing debates regarding the pathophys-
iological signiﬁcance of brain water and low grade cerebral
oedema in MHE.
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Reply to: ‘‘Ammonia and cerebral water. Importance of
structural analysis of the brain in hepatic encephalopathy’’
Letters to the EditorTo the Editor:
We thank McPhail et al. [1] for their comments regarding our
paper [2] in which we reported that induced hyperammonaemia
in patients with hepatic encephalopathy (HE) leads to a transient506 Journal of Hepatology 20increase in brain water apparent diffusion coefﬁcient (ADC)
reported from diffusion tensor imaging (DTI), accompanied by a
decrease in frontal white matter myo-inositol (mI) measured by
proton magnetic resonance spectroscopy (MRS). McPhail et al.12 vol. 56 j 503–510
suggest that assessment of regional brain volume changes using
voxel-based morphometry (VBM) would provide additional evi-
dence available from our existing MR data as to the pathophysi-
ological signiﬁcance of brain water and low grade cerebral
oedema in HE. In response to these comments, we have revisited
the structural scans acquired during our study and performed a
post hoc volumetric analysis of the brain in our patient group
by three different methods.
We compared the baseline 3D T1 weighted volumetric images
(TR/TE 9.6/4.6 ms, ﬂip angle 8, isotropic 1 mm resolution)
against the post amino acid challenge images using VBM
(SPM8) [3] for all subjects in a group analysis to identify any
areas of white and gray matter volume change. As an alternative
measure, we also compared individual subject data using the SIE-
NA approach (Structural Image Evaluation, using Normalisation,
of Atrophy, Version 2.2) [4], which provides a measurement of
the change in total brain volume between baseline and following
the challenge. Finally, we directly subtracted the co-registered
baseline and post challenge images for each subject. Images were
then visual inspected for evidence of volume change around the
brain–CSF boundary [5].
VBM analysis showed no statistically signiﬁcant areas of vol-
ume change in gray or white matter following the amino acid
challenge. Likewise, subtraction of co-registered images did not
reveal any visual evidence of shifts in the brain size. Formal
assessment of boundary shifts using SIENA showed a mean (±
SD) difference in total brain volume of –0.2 (± 0.69) percent
across all subjects, however the SIENA method is accurate to
around 0.2% brain volume change error [4], therefore these
results were deemed insigniﬁcant.
The results from this paired volumetric analysis showed no
signiﬁcant change in brain volume following the challenge. This
is consistent with the original ﬁndings of our paper in which we
concluded that ammonia can directly drive changes in brainwater
distribution, suggesting that glial swelling and the redistribution
of extra-intracellular water during hyperammonaemia are the
likely mechanism of cerebral oedema development in patients
with HE. Our ﬁndings do not support a vasogenic mechanism
for the transient changes in brain water diffusion seen following
transient, induced hyperammonaemia in this subject group.
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C reactive protein levels in non-alcoholic fatty liver disease
To the Editor:
Non-alcoholic fatty liver disease (NAFLD) is the most common
chronic liver disease in the world. It represents a wide spectrum
of conditions ranging from fatty liver, which in general follows a
benign, non-progressive clinical course, to nonalcoholic steato-
hepatitis (NASH), a more serious form of NAFLD that may progress
to cirrhosis and end-stage liver disease. Accurate evaluation of
liver ﬁbrosis in patients with NAFLD is important to identify
patients who may develop complications. Over time, several bio-
logical markers have been studied for evaluating the extent of ste-
atosis, the presence of necroinﬂammation, and the development
of ﬁbrosis to avoid performing liver biopsy, an invasive procedure
that still represents the gold standard of diagnosis. The most
important parameter to be identiﬁed through non-invasive
methods is inﬂammation, as it plays a central role in NAFLD pro-
gression. Several biomarkers of inﬂammation were extensively
studied in relation to fatty liver disease. The C reactive protein
(CRP) is an acute-phase reactant produced by the liver and has
an increased serum concentration in a variety of inﬂammatory
conditions. The assessment of circulating levels of high sensitive
CRP (hsCRP) proved to be useful in differentiating between simple
steatosis and NASH. Moreover, it seems that high concentrations
of hsCRP are associated with extensive liver ﬁbrosis in NASH [1].
In a recent issue of the Journal of Hepatology, Zimmermann
et al. reported the association of hsCRP with various features of
NAFLD in a large obese population. The authors concluded that,
based on their results, hsCRP may be a marker of steatosis, but
not of severity of NAFLD in these patients [2]. The ﬁndings of this
report are interesting and contribute to our understanding of this
issue. However, we have some concerns about the data presented
by the authors.
Firstly, circulating hsCRP levels have been reported to be ele-
vated in subjects with diabetes mellitus (DM) and also prediabe-
tes [3,4]. Although it was stated in the article that some of the
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